Corient Private Wealth’s IBM IBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$128M Sell
454,375
-49,850
-10% -$12.6M 0.18% 113
2026
Q1
$121M Sell
504,225
-8,114
-2% -$2.2M 0.17% 122
2025
Q4
$152M Buy
512,339
+99,690
+24% +$29.9M 0.21% 105
2025
Q3
$114M Buy
412,649
+24,791
+6% +$6.49M 0.18% 120
2025
Q2
$114M Sell
387,858
-130
-0% -$33.5K 0.15% 133
2025
Q1
$96.5M Sell
387,988
-19,694
-5% -$4.82M 0.16% 143
2024
Q4
$87.5M Sell
407,682
-47,429
-10% -$10.6M 0.15% 156
2024
Q3
$101M Buy
455,111
+42,823
+10% +$8.4M 0.16% 141
2024
Q2
$71.3M Buy
412,288
+13,742
+3% +$2.39M 0.12% 171
2024
Q1
$76.1M Sell
398,546
-8,658
-2% -$1.58M 0.14% 167
2023
Q4
$66.6M Buy
407,204
+31,743
+8% +$4.8M 0.12% 173
2023
Q3
$52.7M Buy
375,461
+14,271
+4% +$2.03M 0.12% 181
2023
Q2
$48.3M Buy
361,190
+6,199
+2% +$800K 0.11% 189
2023
Q1
$46.5M Buy
354,991
+76,260
+27% +$10.2M 0.13% 163
2022
Q4
$39.3M Buy
+278,731
New +$38.4M 0.14% 165

Other funds holding IBM

Corient Private Wealth's IBM Position: Q2 2026 in Review

Corient Private Wealth reduced its IBM (IBM) stake by 9.9% in Q2 2026, selling an estimated $12.6M and leaving 454,375 shares worth $128M. The position accounts for 0.18% of the portfolio, ranked #113.

Corient Private Wealth first reported a position in IBM in Q4 2022 and has held it in 15 quarters since. The position peaked at $152M in Q4 2025. 3,633 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • Corient Private Wealth held 454,375 shares of IBM worth $128M as of Q2 2026.
  • Corient Private Wealth sold 49,850 IBM shares in Q2 2026, an estimated $12.6M.
  • IBM made up 0.18% of Corient Private Wealth's portfolio in Q2 2026, its #113 holding.
  • Corient Private Wealth first reported a position in IBM in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's IBM position peaked at $152M in Q4 2025.
  • 3,633 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.